These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20920904)

  • 1. Risk of biliary complications in bariatric surgery.
    Desbeaux A; Hec F; Andrieux S; Fayard A; Bresson R; Pruvot MH; Mulliez E
    J Visc Surg; 2010 Aug; 147(4):e217-20. PubMed ID: 20920904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial).
    Boerlage TCC; Haal S; Maurits de Brauw L; Acherman YIZ; Bruin S; van de Laar AWJM; Moes DE; van Wagensveld BA; de Vries CEE; van Veen R; Schouten R; Dijkgraaf MG; Fockens P; Gerdes VEA; Voermans RP
    BMC Gastroenterol; 2017 Dec; 17(1):164. PubMed ID: 29262795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of symptomatic gallstones after gastric bypass: is prophylactic treatment really necessary?
    Caruana JA; McCabe MN; Smith AD; Camara DS; Mercer MA; Gillespie JA
    Surg Obes Relat Dis; 2005; 1(6):564-7; discussion 567-8. PubMed ID: 16925292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients developed symptomatic gallstones between 3 and 21 months after Roux-en-Y gastric bypass (RYGB), neither prophylactic cholecystectomy nor treatment with ursodeoxycholic acid is necessary after open RYGB.
    Sarr MG
    Surg Obes Relat Dis; 2006; 2(2):233; author reply 233. PubMed ID: 16925352
    [No Abstract]   [Full Text] [Related]  

  • 5. Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients?
    Swartz DE; Felix EL
    Surg Obes Relat Dis; 2005; 1(6):555-60. PubMed ID: 16925290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gallbladder complications after bariatric surgery].
    Veyrie N; Servajean S; Berger N; Loire P; Basdevant A; Bouillot JL
    Gastroenterol Clin Biol; 2007 Apr; 31(4):378-84. PubMed ID: 17483774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallstone disease: Primary and secondary prevention.
    Venneman NG; van Erpecum KJ
    Best Pract Res Clin Gastroenterol; 2006; 20(6):1063-73. PubMed ID: 17127188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gallstones following considerable weight loss and recommendations for their prevention].
    Mijnhout GS; Smulders YM; Craanen ME
    Ned Tijdschr Geneeskd; 2004 Jan; 148(4):174-7. PubMed ID: 14974308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial.
    Haal S; Guman MSS; Boerlage TCC; Acherman YIZ; de Brauw LM; Bruin S; de Castro SMM; van Hooft JE; van de Laar AWJM; Moes DE; Schouten M; Schouten R; van Soest EJ; van Veen RN; de Vries CEE; Fockens P; Dijkgraaf MGW; Gerdes VEA; Voermans RP
    Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):993-1001. PubMed ID: 34715031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial.
    Miller K; Hell E; Lang B; Lengauer E
    Ann Surg; 2003 Nov; 238(5):697-702. PubMed ID: 14578732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Ursodeoxycholic Acid in the Prevention of Cholelithiasis After Sleeve Gastrectomy.
    Coupaye M; Calabrese D; Sami O; Siauve N; Ledoux S
    Obes Surg; 2019 Aug; 29(8):2464-2469. PubMed ID: 30945151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallbladder management in obesity surgery.
    Mason EE; Renquist KE
    Obes Surg; 2002 Apr; 12(2):222-9. PubMed ID: 11975217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical follow up after bariatric surgery: nutritional and drug issues. General recommendations for the prevention and treatment of nutritional deficiencies.
    Ziegler O; Sirveaux MA; Brunaud L; Reibel N; Quilliot D
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):544-57. PubMed ID: 20152742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallstones: Article was disappointing.
    Bateson MC
    BMJ; 2007 Aug; 335(7616):362. PubMed ID: 17717343
    [No Abstract]   [Full Text] [Related]  

  • 15. Ursodeoxycholic acid in the prevention of gallstones in patients subjected to Roux-en-Y gastric bypass1.
    Machado FHF; Castro Filho HF; Babadopulos RFAL; Rocha HAL; Rocha JLC; Moraes Filho MO
    Acta Cir Bras; 2019 Feb; 34(1):e20190010000009. PubMed ID: 30785510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallstone formation after weight loss following gastric banding in morbidly obese Dutch patients.
    Kiewiet RM; Durian MF; van Leersum M; Hesp FL; van Vliet AC
    Obes Surg; 2006 May; 16(5):592-6. PubMed ID: 16687027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of gallstones and gallbladder disease in patients undergoing gastric bypass.
    Quesada BM; Kohan G; Roff HE; Canullán CM; Chiappetta Porras LT
    World J Gastroenterol; 2010 May; 16(17):2075-9. PubMed ID: 20440847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of symptomatic gallstones after bariatric operations.
    Deitel M; Petrov I
    Surg Gynecol Obstet; 1987 Jun; 164(6):549-52. PubMed ID: 3589911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of gallstones by ursodeoxycholic acid after cardiac surgery.
    Ai T; Azemoto R; Saisho H
    J Gastroenterol; 2003; 38(11):1071-6. PubMed ID: 14673725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of cholecystokinin-octapeptide to prevent TPN-associated gallstone disease.
    Tsai S; Strouse PJ; Drongowski RA; Islam S; Teitelbaum DH
    J Pediatr Surg; 2005 Jan; 40(1):263-7. PubMed ID: 15868595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.